BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

Ann: Botanix Announces Cannabidiol Supply Agreement with Purisy, page-103

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,674 Posts.
    lightbulb Created with Sketch. 160
    On FB today
    apologies if already posted
    getting all our ducks in a row - one of those ducks surely has to be a positive announcement for BTX 1503 Phase 2 study

    Botanix has today announced the execution of a synthetic cannabidiol Supply Agreement with Purisys – the world’s leading and most advanced synthetic cannabinoid manufacturer.

    This agreement will provide for immediate clinical and future commercial supplies of synthetic cannabidiol and comes with pricing preferences and exclusivity in our target skin disease areas.

    We’re getting all our ducks in a row, as we fast approach critical milestones in the Botanix Pharmaceuticals clinical research program, including highly anticipated data from the BTX 1503 Phase 2 study (coming soon).

    Read our ASX announcement here http://bit.ly/BOT_Purisys

    No photo description available.



 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
-0.005(1.43%)
Mkt cap ! $627.0M
Open High Low Value Volume
35.0¢ 36.0¢ 34.5¢ $1.255M 3.601M

Buyers (Bids)

No. Vol. Price($)
7 206282 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 316320 5
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.